Clinical Research Directory
Browse clinical research sites, groups, and studies.
Intracameral Levofloxacin Versus Moxifloxacin After Cataract Surgery
Sponsor: Assiut University
Summary
This randomized study aims to compare the safety and efficacy of intracameral levofloxacin versus intracameral moxifloxacin administered at the end of phacoemulsification cataract surgery.
Official title: Comparative Analysis of the Safety and Efficacy of Intracameral Injection of Levofloxacin and Moxifloxacin at the End of Cataract Surgery
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
93
Start Date
2026-09-26
Completion Date
2028-02-25
Last Updated
2026-09-30
Healthy Volunteers
No
Conditions
Interventions
Levofloxacin
0.1 mL of preservative-free levofloxacin 0.5% injected into the anterior chamber at the end of phacoemulsification.
Moxifloxacin
0.1 mL of preservative-free moxifloxacin 0.5% injected into the anterior chamber at the end of phacoemulsification.